Literature DB >> 11860770

[An observation of the immuno-persistence after inoculating with the domestic BRD II strain rubella vaccine among infants and young children].

A Xu1, L Song, C Wang, A Wang, Q Xu, Z Xiao, S Wang, M Li, S Hao, Z Li.   

Abstract

OBJECTIVE: To study the immuno-persistence after inoculating with the domestic BRD II strain rubella vaccine among infants and young children.
METHODS: Hemagglutination inhibition (HI) antibody detection method was used to test on children at age 6 to 18 months without rubella infection or rubella vaccine immunization in Yantai city of Shandong province and were selected for the observation of the immuno-persistence against the domestic BRD II strain rubella vaccine from 1995 to 1998.
RESULTS: Positive rates of HI antibody among children of 6, 7, 8, 9, 12 and 18 month-old of inoculation were 94.44%, 97.22%, 96.67%, 100.00%, 100.00%, 100.00% and 93.10%, 93.55%, 96.77%, 96.97%, 100.00%, 100.00% (P > 0.05), in one or two years respectively. The geometric mean reverse titers (GMRTs) were about 50% lower than that after 1 month after 1 year. Similar results were found that after 2 years GMRTs was about 50% lower than that after 1 year of inoculation. There was highly significant difference on GMRTs of HI antibody between infants with 6 to 7 month-olds (29.89) and young children with 8 to 18 month-olds (53.00) after 2 years of inoculation (t = 3.58, P < 0.001).
CONCLUSION: The immunization schedule at the first dose for BRD II strain rubella vaccine should be started when the child is 8 month old. For the second dose, the immunization schedule used in other developed countries should be referred adopted in China.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11860770

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  3 in total

1.  Rubella virus genotypes in the People's Republic of China between 1979 and 2007: a shift in endemic viruses during the 2001 Rubella Epidemic.

Authors:  Zhen Zhu; Emily Abernathy; Aili Cui; Yan Zhang; Shujie Zhou; Zhenying Zhang; Changyin Wang; Tongzhan Wang; Hua Ling; Chunfang Zhao; Yingqiong Chen; Jilan He; Li Sun; Xia Chen; Jihai Tang; Daxin Feng; Yan Wang; Zhuoma Ba; Lixia Fan; Haiyun Chen; Zhengfan Pan; Jun Zhan; Hui Chen; Shunde Zhou; Lei Zheng; Hui Gao; Yong Liang; Defang Dai; Joseph Icenogle; Wenbo Xu
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

2.  Comparison of four methods using throat swabs to confirm rubella virus infection.

Authors:  Zhen Zhu; Wenbo Xu; Emily S Abernathy; Min-Hsin Chen; Qi Zheng; Tongzhan Wang; Zhenying Zhang; Congyong Li; Changyin Wang; Weikuan He; Shujie Zhou; Joseph Icenogle
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

3.  Adeno-associated viral vectors engineered for macrolide-adjustable transgene expression in mammalian cells and mice.

Authors:  David A Fluri; Marie Daoud-El Baba; Martin Fussenegger
Journal:  BMC Biotechnol       Date:  2007-11-06       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.